3
views
0
recommends
+1 Recommend
0 collections
    0
    shares
      • Record: found
      • Abstract: found
      • Article: found
      Is Open Access

      Impact of sex difference on clinical outcomes in acute myocardial infarction patients with single-vessel and multi-vessel disease: based on Korea Acute Myocardial Infarction Registry-National Institute of Health

      research-article

      Read this article at

      Bookmark
          There is no author summary for this article yet. Authors can add summaries to their articles on ScienceOpen to make them more accessible to a non-specialist audience.

          Abstract

          Background

          Several studies have compared clinical outcomes according to sex in patients with acute myocardial infarction (AMI). However, studies evaluating sex differences in clinical outcomes of single-vessel disease (SVD) and multi-vessel disease (MVD) in Korean patients with AMI are lacking. Therefore, this study aimed to analyze sex differences in the clinical characteristics of patients with AMI with SVD and MVD and to evaluate the impact of sex differences on the clinical outcomes in patients with AMI with SVD and MVD.

          Methods

          A total of 11,002 AMI patients from November 2011 to June 2015 in the Korea AMI Registry, National Institute of Health, were enrolled. The current study was retrospective observational study. Patients were divided into SVD (n=5,644) and MVD (n=5,358) groups, and clinical impact of sex difference were analyzed by propensity score matching analysis and Cox proportional hazard regression model.

          Results

          Women were older and had poor baseline clinical characteristics than men. Propensity score-matched analysis of men and women with SVD and MVD revealed that the adjusted 3-year risk of major adverse cardiac event (MACE) (15.0% vs. 9.4%; hazard ratio, 1.86; 95% confidence interval, 1.10–3.13; P=0.020) was higher in women with SVD aged <65 years. However, the incidence and risk of MACE were similar for men and women with MVD, and those with SVD aged ≥65 years.

          Conclusions

          In the present study of Korean patients with AMI, women were older and exhibited a higher prevalence of comorbidities than men. Women with SVD aged <65 years had a significantly higher risk of MACE.

          Related collections

          Most cited references34

          • Record: found
          • Abstract: found
          • Article: not found

          An Introduction to Propensity Score Methods for Reducing the Effects of Confounding in Observational Studies

          The propensity score is the probability of treatment assignment conditional on observed baseline characteristics. The propensity score allows one to design and analyze an observational (nonrandomized) study so that it mimics some of the particular characteristics of a randomized controlled trial. In particular, the propensity score is a balancing score: conditional on the propensity score, the distribution of observed baseline covariates will be similar between treated and untreated subjects. I describe 4 different propensity score methods: matching on the propensity score, stratification on the propensity score, inverse probability of treatment weighting using the propensity score, and covariate adjustment using the propensity score. I describe balance diagnostics for examining whether the propensity score model has been adequately specified. Furthermore, I discuss differences between regression-based methods and propensity score-based methods for the analysis of observational data. I describe different causal average treatment effects and their relationship with propensity score analyses.
            Bookmark
            • Record: found
            • Abstract: not found
            • Article: not found

            Heart Disease and Stroke Statistics—2015 Update: A Report From the American Heart Association

              Bookmark
              • Record: found
              • Abstract: found
              • Article: not found

              Clinical end points in coronary stent trials: a case for standardized definitions.

              Although most clinical trials of coronary stents have measured nominally identical safety and effectiveness end points, differences in definitions and timing of assessment have created confusion in interpretation. The Academic Research Consortium is an informal collaboration between academic research organizations in the United States and Europe. Two meetings, in Washington, DC, in January 2006 and in Dublin, Ireland, in June 2006, sponsored by the Academic Research Consortium and including representatives of the US Food and Drug Administration and all device manufacturers who were working with the Food and Drug Administration on drug-eluting stent clinical trial programs, were focused on consensus end point definitions for drug-eluting stent evaluations. The effort was pursued with the objective to establish consistency among end point definitions and provide consensus recommendations. On the basis of considerations from historical legacy to key pathophysiological mechanisms and relevance to clinical interpretability, criteria for assessment of death, myocardial infarction, repeat revascularization, and stent thrombosis were developed. The broadly based consensus end point definitions in this document may be usefully applied or recognized for regulatory and clinical trial purposes. Although consensus criteria will inevitably include certain arbitrary features, consensus criteria for clinical end points provide consistency across studies that can facilitate the evaluation of safety and effectiveness of these devices.
                Bookmark

                Author and article information

                Journal
                Cardiovasc Diagn Ther
                Cardiovasc Diagn Ther
                CDT
                Cardiovascular Diagnosis and Therapy
                AME Publishing Company
                2223-3652
                2223-3660
                17 July 2023
                31 August 2023
                : 13
                : 4
                : 660-672
                Affiliations
                [1]deptDepartment of Cardiovascular Medicine, Chonnam National University Hospital , Chonnam National University Medical School , Gwangju, Korea
                Author notes

                Contributions: (I) Conception and design: S Yim, JH Ahn, MH Jeong; (II) Administrative support: Y Ahn, JH Kim, YJ Hong, DS Sim; (III) Provision of study materials or patients: S Yim, JH Ahn, MH Jeong; (IV) Collection and assembly of data: MC Kim, KH Cho, SH Lee, DY Hyun; (V) Data analysis and interpretation: JH Ahn; (VI) Manuscript writing: All authors; (VII) Final approval of manuscript: All authors.

                [#]

                These authors contributed equally to this work.

                Correspondence to: Myung Ho Jeong, MD, PhD, FACC, FSCAI. Department of Cardiology, Cardiovascular Center, Chonnam National University Hospital, Chonnam National University Medical School, 42 Jebong-ro, Dong-gu, Gwangju 61469, Korea. Email: myungho@ 123456chollian.net .
                [^]

                ORCID: Joon Ho Ahn, 0000-0003-3465-6596; Myung Ho Jeong, 0000-0003-2424-810X; Youngkeun Ahn, 0000-0003-2022-9366; Ju Han Kim, 0000-0002-3286-0770; Young Joon Hong, 0000-0003-0192-8161; Doo Sun Sim, 0000-0003-4162-7902; Min Chul Kim, 0000-0001-6026-1702; Kyung Hoon Cho, 0000-0002-0377-6352; Dae Young Hyun, 0000-0002-0038-0125.

                Article
                cdt-13-04-660
                10.21037/cdt-22-536
                10478015
                37675088
                3817acc1-487d-4657-9bac-9c7ece50c2b8
                2023 Cardiovascular Diagnosis and Therapy. All rights reserved.

                Open Access Statement: This is an Open Access article distributed in accordance with the Creative Commons Attribution-NonCommercial-NoDerivs 4.0 International License (CC BY-NC-ND 4.0), which permits the non-commercial replication and distribution of the article with the strict proviso that no changes or edits are made and the original work is properly cited (including links to both the formal publication through the relevant DOI and the license). See: https://creativecommons.org/licenses/by-nc-nd/4.0.

                History
                : 10 November 2022
                : 17 April 2023
                Funding
                Funded by: Research of Korea Centers for Disease Control and Prevention
                Award ID: No. 2016-ER6304-02
                Funded by: National Research Foundation of Korea
                Award ID: Nos. 2019R1A2C3003547, and 2019R1A4A1028534
                Funded by: Ministry of Health & Welfare, Republic of Korea
                Award ID: No. HI18C1352
                Categories
                Original Article

                sex difference,myocardial infarction,single-vessel disease (svd),multi-vessel disease (mvd),prognosis

                Comments

                Comment on this article